Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.630
-0.010 (-0.61%)
At close: Feb 13, 2026
Market Cap14.80B +185.4%
Revenue (ttm)2.30B +19.6%
Net Income-88.36M
EPS-0.01
Shares Out9.08B
PE Ration/a
Forward PE41.16
Dividend0.02 (1.37%)
Ex-Dividend DateSep 26, 2025
Volume20,693,000
Average Volume49,356,663
Open1.620
Previous Close1.640
Day's Range1.600 - 1.630
52-Week Range0.530 - 1.920
Beta1.14
RSI66.47
Earnings DateMar 27, 2026

About HKG:0460

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthet... [Read more]

Sector Healthcare
Founded 2001
Employees 2,767
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0460
Full Company Profile

Financial Performance

In 2024, HKG:0460's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY Financial Statements